SCHEMBL20257514

SCHEMBL20257514

CCOC(=O)N[C@@H](CCc1ccccc1)C(=O)NCCCCN1C(=N)NC(c2ccccc2)(c2ccccc2)C1=O

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA4 P43681 1/20 0.42
SIRT2 Q8IXJ6 7/20 0.41
SIRT1 Q96EB6 5/20 0.41
SIRT3 Q9NTG7 3/20 0.40
FAAH O00519 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CTSS P25774 2/20 0.39
CTSK P43235 1/20 0.39
CTSL P07711 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
TPSAB1 Q15661 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20257403 0.93 L3MBTL1 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4FAAH
SCHEMBL20241404 0.93 AKT1 (0.45) CHRNB2CHRNB4CHRNA3CHRNA4SIRT2
SCHEMBL20257405 0.90 MEN1 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4FAAH
SCHEMBL20257434 0.88 L3MBTL1 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4FAAH
SCHEMBL20257512 0.87 EPHX1 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4FAAH
SCHEMBL20241396 0.86 AKT1 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4SIRT2
SCHEMBL20241812 0.85 AKT1 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4FAAH
SCHEMBL20241617 0.84 AKT1 (0.46) CHRNB2CHRNB4CHRNA3CHRNA4FAAH
SCHEMBL20257432 0.83 NPY1R (0.38) FAAHL3MBTL1KMT2A
SCHEMBL20242089 0.83 FAAH (0.41) FAAHL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018106519-A1 HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-06-14 WO disclosed